SURGICAL DRAINAGE OF A CUTANEOUS / SUBCUTANEOUS ABSCESS
Complete Technical Audit of the Observed Procedure
Asepsis, Antisepsis, Specimen Collection, Packing, Analgesia, Antibiotics and Integrated Therapy
Comprehensive Medical–Surgical Review Updated 2026
By DrRamonReyesMD ⚕️
The images show a procedure compatible with incision and drainage — I&D — of a large cutaneous/subcutaneous abscess, probably located in the gluteal region or proximal thigh.
The visual findings suggest an encapsulated purulent collection under tension, with significant inflammatory oedema, surrounding cellulitis, elevated intralesional pressure and a possible multiloculated cavity. From a medical–surgical standpoint, the procedure appears to have achieved initial evacuation of pus, but several aspects could be improved: antisepsis, field control, procedural analgesia, microbiological sampling and definitive drainage planning.
1. CLINICAL ANALYSIS OF THE CASE
The images show hyperaemic, shiny, tense and oedematous skin, with immediate drainage of thick purulent material. This is compatible with a mature encapsulated abscess, associated with liquefactive necrosis, neutrophilic infiltration, local tissue destruction, intralesional hypoxia, tissue acidosis and increased subcutaneous pressure.
An abscess is not simply “pus under the skin”. It is an organised infectious focus where bacteria, neutrophils, cellular debris, fibrin, proteolytic enzymes and necrotic tissue are trapped inside an inflammatory cavity. This capsule limits antibiotic penetration and explains why antibiotic therapy alone frequently fails without proper source control. IDSA guidelines recommend incision and drainage as the primary treatment for abscesses, carbuncles and large furuncles.
The classical surgical principle remains valid:
Ubi pus, ibi evacua — where there is pus, evacuate it.
2. ABBREVIATIONS USED
I&D: Incision and Drainage.
SSTI: Skin and Soft Tissue Infection.
MSSA: Methicillin-Sensitive Staphylococcus aureus.
MRSA: Methicillin-Resistant Staphylococcus aureus.
CA-MRSA: Community-Associated Methicillin-Resistant Staphylococcus aureus.
HA-MRSA: Healthcare-Associated Methicillin-Resistant Staphylococcus aureus.
TMP/SMX: Trimethoprim/Sulfamethoxazole.
PO: Per os, oral route.
IV: Intravenous.
IM: Intramuscular.
SC: Subcutaneous.
NSAID: Non-Steroidal Anti-Inflammatory Drug.
SIRS: Systemic Inflammatory Response Syndrome.
POCUS: Point-of-Care Ultrasound.
D-test: Microbiological test used to detect inducible clindamycin resistance.
C. difficile: Clostridioides difficile, a bacterium associated with antibiotic-associated colitis.
Source control: Elimination or control of the infectious focus.
3. OBSERVED OR POTENTIAL TECHNICAL ERRORS
3.1. Apparently insufficient surgical field
The images do not clearly show a wide sterile field or generous peripheral antisepsis. A common technical error is cleaning only the incision point, whereas the entire surrounding region should be prepared because sudden pus discharge, contamination of adjacent skin and repeated manipulation of the area may occur during drainage.
Proper antisepsis should cover a broad margin around the abscess. On intact skin, the preferred option is usually alcoholic chlorhexidine, commonly 2% chlorhexidine with 70% isopropyl alcohol, unless contraindicated due to proximity to mucosa, the eye, deep open cavities or extensive devitalised tissue.
3.2. Apparently limited operator protection
A tense abscess can suddenly expel purulent material. Sterile gloves, eye protection, mask, waterproof gown or apron when abundant drainage is expected, sterile gauze and a no-touch technique should be used whenever possible. Aerosolisation or microprojection of pus is a real occupational risk, particularly with MRSA, anaerobes or polymicrobial infections.
3.3. Aggressive manual compression
Manual expression may be useful, but it should be progressive and anatomically directed. Violent compression increases pain, traumatizes inflamed tissue, may promote transient bacteraemia, extend dissection planes or rupture inflammatory barriers. Correct evacuation should combine adequate incision, blunt disruption of septations, irrigation and passive drainage — not merely “squeezing”.
3.4. Possibly insufficient incision for a large cavity
In large abscesses, a microincision may allow initial pus release but favours early closure, incomplete drainage and reaccumulation. The opening must allow evacuation, exploration, disruption of loculations and irrigation. A large cavity requires real source control, not simply an enlarged puncture.
4. CORRECT STEP-BY-STEP PROCEDURE
Clinical assessment should come first: size, location, pain, fever, extent of erythema, immunosuppression, diabetes, obesity, anticoagulation, allergies, pregnancy, previous MRSA history and signs of sepsis. In the gluteal, perianal or perineal region, ischiorectal abscess, anorectal fistula, complex pilonidal disease, hidradenitis suppurativa or early necrotising infection must be ruled out.
When available, POCUS should be used. Bedside ultrasound helps differentiate cellulitis from abscess, measure depth, detect septations, estimate volume, identify foreign bodies and verify residual cavity after drainage.
The skin is prepared with wide antisepsis, sterile drapes are placed and anaesthesia is infiltrated. The incision is made over the point of maximal fluctuance or maximal skin thinning, respecting tension lines and avoiding neurovascular structures. Pus is evacuated, a deep specimen is collected, the cavity is explored with a blunt haemostat, septations are disrupted, sterile saline irrigation is performed and the clinician decides whether to leave free drainage, minimal wick packing or formal packing.
5. MICROBIOLOGICAL SPECIMEN COLLECTION
IDSA guidelines recommend Gram stain and culture of pus from abscesses and carbuncles, although treatment without culture is acceptable in typical uncomplicated cases.
Culture is especially important in recurrent abscesses, treatment failure, immunosuppression, diabetes, sepsis, necrosis, hospitalisation, healthcare exposure, suspected MRSA, IV drug use, hidradenitis suppurativa, deep abscesses, perineal abscesses or polymicrobial infections.
The correct specimen should be taken from the deep interior of the cavity, ideally after opening and before abundant irrigation. It should not be taken from external skin or superficially contaminated pus.
The objective is to identify MSSA, MRSA, beta-haemolytic streptococci, anaerobes, Enterobacterales, polymicrobial flora and, in special contexts, mycobacteria or fungi. The antibiogram guides targeted therapy and allows detection of inducible clindamycin resistance through the D-test.
6. PACKING, WICK OR FREE DRAINAGE
Modern practice is selective. Routine packing of simple abscesses has lost support because it increases pain and does not consistently reduce recurrence or treatment failure. Trials and reviews comparing packing versus no packing in superficial cutaneous abscesses have not demonstrated clear benefit in all patients, especially when the abscess has been adequately drained.
Avoid routine packing
Packing may be avoided in small, simple, superficial, well-evacuated abscesses without tunnels, without immunosuppression and with reliable follow-up.
Use wick or drainage when appropriate
Packing or wick drainage may be useful in large, deep, multiloculated cavities, abscesses with sinus tracts, pilonidal disease, hidradenitis suppurativa, immunosuppression, high risk of premature closure or persistent drainage.
Dry wick
Simple sterile gauze maintains the opening and allows passive drainage, but it is painful, adheres to tissue and may cause trauma during removal.
Medicated wick
Iodoform gauze or antimicrobial-impregnated gauze may reduce colonisation, but it may also irritate tissue, cause cytotoxicity if overused and delay granulation. The prudent modern tendency is minimal packing, never tight packing. The wick should act as a drainage pathway, not as an obstructive plug.
7. PROCEDURAL ANALGESIA AND ANAESTHESIA
Drainage of a large abscess can be extremely painful. Undertreating pain is both a clinical and ethical error.
Local anaesthesia
Lidocaine 1–2% is standard. It may be used with epinephrine/adrenaline to prolong effect and reduce bleeding, avoiding use where contraindicated according to clinical judgement. Infected acidic tissue reduces anaesthetic efficacy, which explains why the procedure may still be painful despite infiltration.
Ways to improve anaesthesia include infiltrating around the lesion rather than directly into the purulent centre, using a fine needle, injecting slowly, allowing enough time for onset, considering buffered lidocaine with bicarbonate when available and using a regional block when anatomy allows.
Systemic analgesia
Large abscesses may require local anaesthesia combined with systemic analgesia.
Paracetamol/acetaminophen: useful as baseline analgesia, avoiding overdose and adjusting in liver disease.
NSAIDs — non-steroidal anti-inflammatory drugs: ibuprofen, dexketoprofen or ketorolac may be useful if there is no renal failure, gastrointestinal bleeding, high-risk anticoagulation, allergy, advanced pregnancy or relevant cardiovascular contraindication.
Opioids: morphine, fentanyl or oxycodone may be required for extensive procedures or severe pain. They require respiratory, haemodynamic and neurological monitoring.
Ketamine: in analgesic or procedural sedation doses, it may be useful for extremely painful drainage, agitated patients or prolonged procedures. It requires monitoring, trained personnel and airway management capability.
8. EMPIRIC ANTIBIOTIC THERAPY 2026
The central principle is clear: in a true abscess, drainage is the main treatment. The CDC also emphasises that the main treatment for MRSA skin infections is incision and drainage, although antibiotics may be required depending on severity and clinical context.
Antibiotics are indicated when there is extensive cellulitis, fever, SIRS, sepsis, immunosuppression, diabetes, morbid obesity, large abscess, multiple lesions, facial location, deep infection, necrosis, previous treatment failure, extremes of age or high MRSA risk. Empiric MRSA coverage may be justified according to systemic symptoms, local severity and epidemiological context.
Common oral options
TMP/SMX — trimethoprim/sulfamethoxazole: good option for CA-MRSA. Limitation: variable streptococcal coverage. It may be combined with a beta-lactam if relevant streptococcal cellulitis is suspected.
Doxycycline: useful against many CA-MRSA strains. Limitation: less reliable streptococcal coverage. Avoid in pregnancy and assess paediatric use according to local guidelines.
Clindamycin: covers susceptible MRSA and streptococci; may inhibit toxin production. Problems: resistance, need for D-test and risk of Clostridioides difficile colitis.
Cephalexin/amoxicillin-clavulanate: useful when non-purulent cellulitis or polymicrobial flora predominates, but cephalexin does not cover MRSA. Amoxicillin-clavulanate may be reasonable in bites, perineal infections, mixed flora or anaerobic risk, depending on context.
Clinical trials have shown that TMP/SMX or clindamycin added to drainage can modestly improve outcomes in simple abscesses compared with placebo, although the decision must be individualised.
Severe or hospital-level cases
In severe infection, sepsis, necrosis, immunosuppression or outpatient treatment failure: hospital assessment, blood cultures when appropriate, laboratory workup, lactate, imaging, surgical evaluation and IV antibiotics are indicated.
Options according to severity and epidemiology:
Vancomycin IV: classic standard when severe MRSA infection is suspected.
Linezolid: excellent oral and IV bioavailability, good tissue penetration, active against MRSA; monitor for myelosuppression, serotonergic interactions and neuropathy with prolonged use.
Daptomycin: useful in bacteraemia and complicated skin infections; not useful for pneumonia. Monitor CPK and myopathy.
Ceftaroline: cephalosporin with MRSA activity.
Piperacillin-tazobactam or carbapenems: if severe polymicrobial, perineal, necrotising or nosocomial infection is suspected, combined with MRSA coverage when appropriate.
9. OFF-LABEL / ADVANCED THERAPY
In recurrent S. aureus or MRSA infections, decolonisation may be considered, always with clinical and epidemiological judgement:
Intranasal mupirocin: usually used as a short course for nasal S. aureus carriers; may be considered off-label depending on the specific indication and local regulations.
Chlorhexidine washes: reduce skin colonisation in selected patients.
Environmental decontamination: washing towels, sheets, sportswear, gym equipment and shared objects.
Rifampicin combination therapy: never as monotherapy due to rapid resistance selection. Only in specific scenarios, with specialist input, and usually in combination.
10. AFTERCARE
After drainage, the wound should be covered with a sterile absorbent dressing, bleeding should be controlled, and the following should be documented: size, location, approximate pus volume, odour, presence of necrosis, specimen sent and antibiotic prescribed.
Reassessment is usually recommended within 24–48 hours if the abscess is large, if packing was left in place, if cellulitis is present or if the patient has risk factors.
The patient should be instructed to seek urgent care if fever, worsening pain, rapidly expanding erythema, necrosis, crepitus, strong foul odour, hypotension, confusion, persistent vomiting, lymphangitic streaking or systemic deterioration occurs.
11. DIFFERENTIAL DIAGNOSIS AND COMPLICATIONS
Differential diagnoses include infected epidermoid cyst, hidradenitis suppurativa, pilonidal abscess, infected haematoma, infected seroma, carbuncle, cellulitis without collection, foreign body, deep perianal abscess, fistula, necrotising infection and osteomyelitis if deep or chronic.
Possible complications include recurrence, extensive cellulitis, bacteraemia, sepsis, necrotising fasciitis, fistulas, pathological scarring, chronic pain and persistent drainage.
12. FINAL DRRAMONREYESMD CONCEPT
Success does not depend on merely “opening and draining pus”. It depends on true source control:
adequate drainage, proper incision, disruption of septations, rational irrigation, correct microbiological sampling, dignified analgesia, intelligent decision-making regarding packing, antibiotics only when indicated, early reassessment and surveillance for complications.
In this case, the initial drainage appears necessary and clinically justified, but the 2026 standard demands more: better field preparation, better antisepsis, operator protection, deep sampling when appropriate, POCUS when available, robust analgesia and a structured follow-up strategy.
Essential References
IDSA — Skin and Soft Tissue Infections Guidelines.
CDC — Clinical Overview of MRSA.
NEJM — Antibiotics after drainage of skin abscesses. DOI: 10.1056/NEJMoa1607033.
NEJM — Clindamycin versus TMP/SMX for uncomplicated skin infections. DOI: 10.1056/NEJMoa1403789.
Kessler et al. — Packing vs no packing after I&D.
No hay comentarios:
Publicar un comentario